Ginwa Enterprise Group Inc
SSE:600080
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ginwa Enterprise Group Inc
Long-Term Debt
Ginwa Enterprise Group Inc
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Ginwa Enterprise Group Inc
SSE:600080
|
Long-Term Debt
¥12.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Long-Term Debt
¥47.6m
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Long-Term Debt
¥43.3m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Long-Term Debt
¥779.6m
|
CAGR 3-Years
39%
|
CAGR 5-Years
84%
|
CAGR 10-Years
-1%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Long-Term Debt
¥4.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
46%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Long-Term Debt
¥1.2B
|
CAGR 3-Years
129%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ginwa Enterprise Group Inc
Glance View
Ginwa Enterprise (Group) Inc. engages in the manufacture and distribution of pharmaceuticals. The company is headquartered in Xi'An, Shaanxi and currently employs 607 full-time employees. The firm's main product is jintiange capsules, used for treatment of osteoporosis. The firm provides products in various forms, including tablets, oral solutions, capsules and others. In addition, the Company involves in the provision of hotel services and operation of rental business. Through its subsidiaries, the Company is involved in hotel operation business, wholesale and retail of pharmaceuticals and medical devices, as well as television drama production businesses and others.
See Also
What is Ginwa Enterprise Group Inc's Long-Term Debt?
Long-Term Debt
12.9m
CNY
Based on the financial report for Sep 30, 2025, Ginwa Enterprise Group Inc's Long-Term Debt amounts to 12.9m CNY.
What is Ginwa Enterprise Group Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
-24%
Over the last year, the Long-Term Debt growth was 32%. The average annual Long-Term Debt growth rates for Ginwa Enterprise Group Inc have been 2% over the past three years , -24% over the past five years .